WE ARE

A pharmaceutical company specialized in high quality

ONCOLOGY PRODUCTS

 

ABOUT US

MANUFACTURING EXCELLENCE 

CURRENT ONCOLOGY REVIEW

MAGAZINE

27/08/2019

ACTERO LAUNCHES IMATINIB ACTE AND NILOTINIB ACTE

Actero Middle East is pleased to announce the launch of two new molecules to the Iranian market: Imatinib ACTe 100mg and Nilotinib ACTe 200mg. »MORE

06/07/2019

WE ARE NOT JUST IMAGINING THE FUTURE – WE DO CREATE IT!

The ACTERO pharmaceutical company is honored to announce the launch of its new scientific product in the field, The Journal of Current Oncology! »MORE

PRODUCTS

We are building a unique range of products to cover the needs of cancer patients. Actero is not only focused on chemotherapy, but understands cancer treatment as a whole. That is why we invest in high quality oncology drugs, as well as in palliative care»MORE

RESPONSIBILITY

We understand that pharmaceutical industry is not comparable to other industries. That is why ethical behavior is at the heart of our business.

» MORE